A rare lymphoproliferative disorder associated with immunomodulating therapy in Crohn's disease

Rev Esp Enferm Dig. 2019 Jun;111(6):491. doi: 10.17235/reed.2019.5990/2018.

Abstract

Lymphomatoid granulomatosis is a rare lymphoproliferative disorder associated with immunosuppressive therapy in inflammatory bowel disease. We present the case of a patient with Crohn's disease and treated azathioprine that develops lymphomatoid granulomatosis, as well as its diagnostic process and the chosen treatment. Lymphomatoid granulomatosis is a serious disease barely described and whose suspicion is essential for its prognosis.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Azathioprine / adverse effects*
  • Azathioprine / therapeutic use
  • Crohn Disease / drug therapy*
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Immunosuppressive Agents / therapeutic use
  • Lymphomatoid Granulomatosis / chemically induced*
  • Male
  • Middle Aged
  • Skin Neoplasms / chemically induced*

Substances

  • Immunosuppressive Agents
  • Azathioprine